APO RESEARCH · REPORT
Latanoprost
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Product & engineering
Understand the product.
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
In the report, one unit refers to one bottle.
Selected research
Industry Research
Latanoprost Industry Research Report 2026
Market perspective
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
In the report, one unit refers to one bottle.
Read the full market overview
Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share. North America is the major region of the global market, which takes about 35% market share.
Report Scope
This report quantifies the global Latanoprost market in terms of revenue (US$ million) and, where applicable, sales volume (M Unit), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Unit) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Latanoprost Market by Company
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu
Latanoprost Segment by Type
Brand Drug
Generic Drug
Latanoprost Segment by Application
Open-angle Glaucoma
Close-angle Glaucoma
Latanoprost Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Latanoprost market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Latanoprost and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Latanoprost.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Latanoprost manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Latanoprost by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Latanoprost in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Brand Drug
- Generic Drug
Applications
- Open-angle Glaucoma
- Close-angle Glaucoma
Companies covered
- Pfizer
- Mylan
- Novartis
- Apotex
- Teva
- Taj Pharma
- CR Zizhu
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Latanoprost Market Size (2021-2032)
- 2.2.2 Global Latanoprost Sales (2021-2032)
- 2.2.3 Global Latanoprost Market Average Price (2021-2032)
- 2.3 Latanoprost by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Brand Drug
- 2.3.3 Generic Drug
- 2.4 Latanoprost by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Open-angle Glaucoma
- 2.4.3 Close-angle Glaucoma
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Latanoprost Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Latanoprost Sales (M Unit) of Manufacturers (2021-2026)
- 3.3 Global Latanoprost Revenue of Manufacturers (2021-2026)
- 3.4 Global Latanoprost Average Price by Manufacturers (2021-2026)
- 3.5 Global Latanoprost Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Latanoprost, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Latanoprost, Product Type & Application
- 3.8 Global Manufacturers of Latanoprost, Established Date
- 3.9 Global Latanoprost Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pfizer
- 4.1.1 Pfizer Company Information
- 4.1.2 Pfizer Business Overview
- 4.1.3 Pfizer Latanoprost Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pfizer Latanoprost Product Portfolio
- 4.1.5 Pfizer Recent Developments
- 4.2 Mylan
- 4.2.1 Mylan Company Information
- 4.2.2 Mylan Business Overview
- 4.2.3 Mylan Latanoprost Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mylan Latanoprost Product Portfolio
- 4.2.5 Mylan Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Latanoprost Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Latanoprost Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 Apotex
- 4.4.1 Apotex Company Information
- 4.4.2 Apotex Business Overview
- 4.4.3 Apotex Latanoprost Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Apotex Latanoprost Product Portfolio
- 4.4.5 Apotex Recent Developments
- 4.5 Teva
- 4.5.1 Teva Company Information
- 4.5.2 Teva Business Overview
- 4.5.3 Teva Latanoprost Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Teva Latanoprost Product Portfolio
- 4.5.5 Teva Recent Developments
- 4.6 Taj Pharma
- 4.6.1 Taj Pharma Company Information
- 4.6.2 Taj Pharma Business Overview
- 4.6.3 Taj Pharma Latanoprost Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Taj Pharma Latanoprost Product Portfolio
- 4.6.5 Taj Pharma Recent Developments
- 4.7 CR Zizhu
- 4.7.1 CR Zizhu Company Information
- 4.7.2 CR Zizhu Business Overview
- 4.7.3 CR Zizhu Latanoprost Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 CR Zizhu Latanoprost Product Portfolio
- 4.7.5 CR Zizhu Recent Developments
5 Global Latanoprost Market Scenario by Region
- 5.1 Global Latanoprost Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Latanoprost Sales by Region: 2021-2032
- 5.2.1 Global Latanoprost Sales by Region: 2021-2026
- 5.2.2 Global Latanoprost Sales by Region: 2027-2032
- 5.3 Global Latanoprost Revenue by Region: 2021-2032
- 5.3.1 Global Latanoprost Revenue by Region: 2021-2026
- 5.3.2 Global Latanoprost Revenue by Region: 2027-2032
- 5.4 North America Latanoprost Market Facts & Figures by Country
- 5.4.1 North America Latanoprost Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Latanoprost Sales by Country (2021-2032)
- 5.4.3 North America Latanoprost Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Latanoprost Market Facts & Figures by Country
- 5.5.1 Europe Latanoprost Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Latanoprost Sales by Country (2021-2032)
- 5.5.3 Europe Latanoprost Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Latanoprost Market Facts & Figures by Country
- 5.6.1 Asia Pacific Latanoprost Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Latanoprost Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Latanoprost Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Latanoprost Market Facts & Figures by Country
- 5.7.1 South America Latanoprost Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Latanoprost Sales by Country (2021-2032)
- 5.7.3 South America Latanoprost Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Latanoprost Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Latanoprost Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Latanoprost Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Latanoprost Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Latanoprost Sales by Type (2021-2032)
- 6.1.1 Global Latanoprost Sales by Type (2021-2032) & (M Unit)
- 6.1.2 Global Latanoprost Sales Market Share by Type (2021-2032)
- 6.2 Global Latanoprost Revenue by Type (2021-2032)
- 6.2.1 Global Latanoprost Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Latanoprost Revenue Market Share by Type (2021-2032)
- 6.3 Global Latanoprost Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Latanoprost Sales by Application (2021-2032)
- 7.1.1 Global Latanoprost Sales by Application (2021-2032) & (M Unit)
- 7.1.2 Global Latanoprost Sales Market Share by Application (2021-2032)
- 7.2 Global Latanoprost Revenue by Application (2021-2032)
- 7.2.1 Global Latanoprost Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Latanoprost Revenue Market Share by Application (2021-2032)
- 7.3 Global Latanoprost Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Latanoprost Value Chain Analysis
- 8.1.1 Latanoprost Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Latanoprost Production Mode & Process
- 8.2 Latanoprost Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Latanoprost Distributors
- 8.2.3 Latanoprost Customers
9 Global Latanoprost Analyzing Market Dynamics
- 9.1 Latanoprost Industry Trends
- 9.2 Latanoprost Industry Drivers
- 9.3 Latanoprost Industry Opportunities and Challenges
- 9.4 Latanoprost Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst